Ledger.Open graph →
SEC Form D · filed December 14, 2021

NERVGEN PHARMA CORP

Offering
$1.1M
Sold
$652K
Exemption
Rule 506(b)
Industry
Other
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Bill Radvak · Vancouver, British Columbia, CanadaDirectorMichael Abrams · Vanouver, British Columbia, CanadaDirectorWilliam Adams · Vancouver, British Columbia, CanadaExecDaniel Mikol · Vancouver, British Columbia, CanadaExecPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorRandall Kaye · Vancouver, British Columbia, CanadaDirectorHarold J. Punnett · Vancouver, British Columbia, CanadaDirectorBrian J. Bayley · Vancouver, British Columbia, CanadaDirectorBruce Cassidy · Sarasota, FLDirectorJacob L. Block · Grove City, OHExecJane N. Wilkinson · Luxembourg, LuxembourgExecRoger Tichenor · Sarasota, FLDirectorZarrell R. Gray · Zionsville, INDirectorRichard R. Halderman · Zionsville, INDirectorBesar N. Muhameti · Luxembourg, LuxembourgDirectorRod W. Saddington · DALLAS, TXExec · DirectorGlenn Ives · Vancouver, British Columbia, CanadaDirectorKrista Mckerracher · Vancouver, British Columbia, CanadaDirectorAndrew Hemingway · Bristol, NHDirectorMLG Fund Manager LLC · Brookfield, WIDirectorYuriy Gordiyenko · Brooklyn, NYDirectorMikhail Zlotnik · Brooklyn, NYDirectorYuriy Novodvorskiy · Brooklyn, NYExec · DirectorAlina Trigub · Brooklyn, NYExecDaniel A. Gold · New York, NYDirectorBrent E. Carey · Long Beach, CAExecGlenn Ives · Vancouver, British Columbia, CanadaDirectorKrista Mckerracher · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗